Biofourmis

Gaido Health is a technology company that develops an AI-driven platform focused on the continuous monitoring of post-discharge oncology patients. The platform employs proprietary machine learning algorithms to monitor patient health, aiming to detect early signs of deterioration. By concentrating on post-discharge oncology care, Gaido Health enhances the quality of care and outcomes for patients, allowing clinicians to quickly triage and efficiently follow up with those identified as high-risk. The company's innovative approach addresses the critical need for improved patient management following hospital discharge, ultimately supporting better clinical decision-making and patient health.

Biovotion AG is a medical device company based in Zurich, Switzerland, specializing in continuous and non-invasive monitoring of physiological and metabolic processes. The company has developed a wearable sensing technology that enables medical-quality vital sign monitoring (VSM) for everyday use. Their flagship product, the Vital Sign Monitor, is a mobile, standalone device designed to measure blood circulation parameters effectively in home settings. This multi-sensor platform integrates advanced algorithms with cloud infrastructure, allowing for real-time access to data comparable to standard hospital systems. The technology currently monitors various parameters, including heart rate, blood oxygenation, blood perfusion, temperature, and movement/activity, with plans to expand to additional metrics such as heart rate variability and sleep monitoring. Biovotion also offers consulting services in medical device development, focusing on technical due diligence, clinical strategies, and quality management. The company operates as a subsidiary of Biofourmis Singapore Pte. Ltd.